Dominik A. Rothen

Bern, BE 3008, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses.

Versatile and Scalable Nanoparticle Vaccine as a Scaffold Against Newly Emerging Influenza Viruses.

Journal: Viruses
Published: July 11, 2025

Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity.

Targeted Lymph Node Immunization with Serotype-Specific Dengue VLP Vaccines Enhances Antibody Avidity and Specificity.

Journal: Vaccines
Published: July 07, 2025

Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874.

Correction: Rothen et al. Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes. Vaccines 2024, 12, 874.

Journal: Vaccines
Published: October 07, 2024

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines.

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines.

Journal: Vaccines
Published: July 23, 2024

Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes.

Preclinical Evaluation of Novel Sterically Optimized VLP-Based Vaccines against All Four DENV Serotypes.

Journal: Vaccines
Published: July 03, 2024

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.

Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response.

Journal: Vaccines
Published: March 18, 2024

Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.

Probing novel epitopes on the Plasmodium falciparum circumsporozoite protein for vaccine development.

Journal: NPJ vaccines
Published: February 29, 2024

Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach.

Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach.

Journal: Vaccines
Published: February 26, 2024

Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.

Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.

Journal: Allergy
Published: September 29, 2021

A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.

A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2.

Journal: Allergy
Published: July 12, 2021

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.

AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate.

Journal: Vaccines
Published: March 11, 2021

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine.

Neutralization of MERS coronavirus through a scalable nanoparticle vaccine.

Journal: NPJ vaccines
Published: February 22, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026